↓ Skip to main content

Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration

Overview of attention for article published in New England Journal of Medicine, October 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

blogs
1 blog
patent
3 patents

Readers on

mendeley
78 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration
Published in
New England Journal of Medicine, October 2010
DOI 10.1056/nejmct1000495
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 78 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Japan 2 3%
Peru 1 1%
United Kingdom 1 1%
Germany 1 1%
Belgium 1 1%
Australia 1 1%
Unknown 71 91%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 19 24%
Other 13 17%
Student > Bachelor 8 10%
Student > Ph. D. Student 6 8%
Professor 5 6%
Other 11 14%
Unknown 16 21%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 38 49%
Agricultural and Biological Sciences 11 14%
Biochemistry, Genetics and Molecular Biology 3 4%
Chemistry 3 4%
Economics, Econometrics and Finance 2 3%
Other 5 6%
Unknown 16 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 April 2026.
All research outputs
#6,092,839
of 34,357,314 outputs
Outputs from New England Journal of Medicine
#22,899
of 38,365 outputs
Outputs of similar age
#28,692
of 154,490 outputs
Outputs of similar age from New England Journal of Medicine
#119
of 204 outputs
Altmetric has tracked 34,357,314 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 38,365 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 120.2. This one is in the 39th percentile – i.e., 39% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 154,490 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 204 others from the same source and published within six weeks on either side of this one. This one is in the 39th percentile – i.e., 39% of its contemporaries scored the same or lower than it.